查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654214

细胞治疗成分市场规模、份额、趋势分析报告：按产品、最终用途、地区、细分市场预测，2025 年至 2030 年

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera, Antibodies, Reagents & Buffers, Cell Culture Supplements), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

细胞治疗材料市场的成长和趋势

根据Grand View Research, Inc.的一份新报告，到2030年全球细胞治疗材料市场规模预计将达到125.9亿美元。

预计 2025 年至 2030 年间，市场复合年增长率将达到 18.16%。预计对各种细胞药物研发的投资增加以及许多国家政府对各种临床研究的投资增加将有助于市场的成长。此外，新兴国家生物製药和生物技术产业的不断发展将进一步推动预测期内的市场成长。

COVID-19疫情对细胞治疗材料产业产生了重大影响。随着病毒在全球蔓延，供应链中断、劳动力短缺和运输限制对製造细胞疗法所需的关键原材料的生产和分配构成了重大挑战。许多供应商在采购和交付生长因子、培养基和生物反应器等基本成分时面临延误。结果，细胞治疗公司经历了生产放缓和成本增加。此外，疫情期间对医疗用品的需求增加，导致资源紧张并导致价格波动。儘管面临这些挑战，细胞治疗产业仍透过适应新的筹资策略和监管变化表现出了韧性，凸显了供应链多样化和为不可预见的全球危机做好准备的重要性。

此外，预计细胞治疗产业将见证生物製药公司的进步和创新的大幅成长。对于治疗各种疾病和病症的有效细胞疗法的需求日益增长，将进一步推动这些进步。此外，预计预测期内各种生物技术和製药公司的扩张将进一步推动市场成长。

细胞疗法製造的不断扩张以及 FDA核准的增加为原材料市场带来了许多机会。一些製造商正在开设此类设施，以扩大其在细胞治疗领域的影响力。例如，2023年6月，百时美施贵宝获得美国FDA核准，在其位于麻萨诸塞州德文斯的新细胞疗法製造工厂开始商业化生产。为了确保公司治疗产品组合的长期供应，Devens 工厂是 BMS 全球细胞治疗製造基础设施的重要组成部分。

然而，成本和定价正在限制市场的成长。这些对于细胞疗法生产至关重要的材料的取得和製造成本很高。这种成本负担增加了开发和提供细胞治疗方法的费用，并且可能由于财务限製而限制更多人群获得治疗。平衡品质和价格是推动细胞疗法和确保其在医疗行业更广泛可用和接受的关键挑战。

细胞治疗材料市场报告重点

  • 市场按产品细分为培养基、血清、细胞培养补充剂、抗体、试剂和缓衝液等。 2024 年，细胞培养补充剂部分占据最大的市场占有率，为 25.27%。
  • 根据最终用途，市场细分为生物製药和製药公司、CMO 和 CRO 以及其他。 2024年，生物製药和製药公司板块占据最大的市场占有率，为53.54%。
  • 2024 年北美占据细胞治疗原料产业的主导地位，份额为 47.30%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第四章 产品业务分析

  • 产品细分仪表板
  • 细胞治疗材料市场：产品变化分析
  • 2018 年至 2030 年细胞治疗原料市场规模及趋势分析（依产品分类）
  • 培养基
    • 文化媒体市场，2018-2030
  • 血清
    • 血清市场，2018-2030
  • 细胞培养补充剂
    • 细胞培养补充品市场，2018-2030 年
  • 抗体
    • 抗体市场，2018 - 2030
  • 试剂和缓衝溶液
    • 2018 至 2030 年试剂与缓衝液市场
  • 其他的
    • 其他市场，2018-2030

第五章 最终用途业务分析

  • 细胞治疗材料市场：最终用途趋势分析
  • 生物製药和製药公司
    • 2018-2030 年生物製药和医药市场
  • 合约研究公司・合约行销公司
    • CRO/CMO 市场，2018 年至 2030 年
  • 其他的
    • 其他市场，2018-2030

第六章 区域经营分析

  • 细胞治疗材料市场占有率（按地区划分） (2024 年和 2030 年)
  • 北美洲
    • 2018 至 2030 年北美细胞治疗材料市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 至 2030 年欧洲细胞治疗材料市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太细胞治疗材料市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲细胞治疗材料市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东和非洲细胞治疗材料市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司分类
  • 战略地图
  • Company Position Analysis, 2024
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Actylis.
    • ACROBiosystems
    • STEMCELL Technologies
    • Grifols, SA
    • Charles River Laboratories
    • RoosterBio, Inc.
    • PromoCell GmbH
    • Danaher
    • Sartorius Stedim BIoTech
Product Code: GVR-4-68040-137-9

Cell Therapy Raw Materials Market Growth & Trends:

The global cell therapy raw materials market size is anticipated to reach USD 12.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.16% from 2025 to 2030. The rising investments in the research and development of various cell-based drugs and the increasing number of government investments in numerous countries for various clinical studies are anticipated to contribute to the growth of the market. Moreover, the growing developments in the biopharmaceutical & biotechnology industry in developing countries are further fueling the growth of the market over the forecast period.

The COVID-19 pandemic had a significant impact on the cell therapy raw materials industry. As the virus spread globally, disruptions in supply chains, workforce shortages, and transportation restrictions posed significant challenges to the production and distribution of critical raw materials required for cell therapy manufacturing. Many suppliers faced delays in the sourcing and delivery of essential components, such as growth factors, culture media, and bioreactors. This resulted in production slowdowns and increased costs for cell therapy companies. In addition, the heightened demand for medical supplies during the pandemic strained resources and led to price fluctuations. Despite these challenges, the cellular therapy industry demonstrated resilience by adapting to new sourcing strategies and regulatory changes, emphasizing the importance of supply chain diversification and preparedness in the face of unforeseen global crises.

Moreover, the cell therapy industry is anticipated to witness a significant surge in advancements and innovations by biopharma companies. These advances would be further propelled by the growing demand for effective cell-based therapies to treat a range of diseases and medical conditions. Furthermore, the growing expansion of various biotechnology and pharmaceutical companies is further expected to propel the growth of the market over the forecast period.

The increasing expansion of cellular therapy manufacturing along with rising FDA approvals are opening numerous opportunities for the raw materials market. Several manufacturers are opening such facilities to increase their footprint in the cellular therapy field. For instance, in June 2023, Bristol Myers Squibb received approval from the U.S. FDA to start its commercial production at its new cell therapy production facility in Devens, Massachusetts. For the long-term supply of the company's therapy portfolio, the Devens site is a crucial part of BMS' growing worldwide cell therapy production infrastructure.

However, the cost and affordability restrain the growth of the market. These materials, vital for cell therapy production, are costly to obtain and manufacture. This cost burden increases the expenses in the development and provision of cell-based therapies, potentially limiting their accessibility to a broader population due to financial constraints. Balancing quality and affordability is an acute concern in advancing cell therapies and ensuring their broader availability and acceptance within the healthcare industry.

Cell Therapy Raw Materials Market Report Highlights:

  • Based on product, the market is segmented into media, sera, cell culture supplements, antibodies, reagents & buffers, and others. The cell culture supplements segment held the largest market share of 25.27% in 2024.
  • Based on the end use, the market is segmented into biopharmaceutical & pharmaceutical companies, CMOs & CROs, and others. The biopharmaceutical & pharmaceutical companies segment held the largest market share of 53.54% in 2024.
  • North America dominated the cell therapy raw materials industry with a share of 47.30% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
  • 4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Media
    • 4.4.1. Media Market, 2018 - 2030 (USD Million)
  • 4.5. Sera
    • 4.5.1. Sera Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Culture Supplements
    • 4.6.1. Cell Culture Supplements Market, 2018 - 2030 (USD Million)
  • 4.7. Antibodies
    • 4.7.1. Antibodies Market, 2018 - 2030 (USD Million)
  • 4.8. Reagents & Buffers
    • 4.8.1. Reagents & Buffers Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
  • 5.2. Biopharmaceutical & Pharmaceutical Companies
    • 5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. CROs & CMOs
    • 5.3.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Therapy Raw Materials Market Share By Region, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Position Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Actylis.
      • 7.4.3.1. Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Strategic Initiatives
    • 7.4.4. ACROBiosystems
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. STEMCELL Technologies
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Grifols, S.A.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Charles River Laboratories
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. RoosterBio, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. PromoCell GmbH
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. Danaher
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 Global cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 2 Global cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 3 Global cell therapy raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 9 Canada cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 11 Mexico cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 12 Mexico cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 13 Europe cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 16 UK cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 18 Germany cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 20 France cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 21 France cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 22 Italy cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 24 Spain cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 26 Denmark cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 28 Sweden cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 30 Norway cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 31 Norway cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 35 Japan cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 36 Japan cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 37 China cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 38 China cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 39 India cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 40 India cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 41 Australia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 43 South Korea cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 44 South Korea cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 45 Thailand cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 47 Latin America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 50 Brazil cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 51 Brazil cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 52 Argentina cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 53 Argentina cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 57 South Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 61 UAE cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 62 UAE cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
  • Table 65 Key companies undertaking acquisitions
  • Table 66 Key companies launching new products/services
  • Table 67 Key companies undertaking collaborations and partnerships
  • Table 68 Key companies undertaking other initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Cell therapy raw materials market segmentation
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Value-chain-based sizing & forecasting
  • Fig. 10 QFD modelling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Commodity flow analysis
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 Porter's five force analysis
  • Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 20 Cell therapy raw materials market: product outlook key takeaways
  • Fig. 21 Cell therapy raw materials market: product movement analysis
  • Fig. 22 Media market, 2018 - 2030 (USD Million)
  • Fig. 23 Sera market, 2018 - 2030 (USD Million)
  • Fig. 24 Cell culture supplements market, 2018 - 2030 (USD Million)
  • Fig. 25 Antibodies market, 2018 - 2030 (USD Million)
  • Fig. 26 Reagents & buffers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Cell therapy raw materials market: end Use outlook key takeaways
  • Fig. 29 Cell therapy raw materials market: end Use movement analysis
  • Fig. 30 Biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 31 CROs & CMOs supplements market, 2018 - 2030 (USD Million)
  • Fig. 32 Others supplements market, 2018 - 2030 (USD Million)
  • Fig. 33 Cell therapy raw materials market revenue, by region, 2022 & 2030 (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 North America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 US cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 US Key country dynamics
  • Fig. 38 Canada cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Key country dynamics
  • Fig. 40 Mexico cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Key country dynamics
  • Fig. 42 Europe cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK Key country dynamics
  • Fig. 45 Germany cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany Key country dynamics
  • Fig. 47 France cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France Key country dynamics
  • Fig. 49 Spain cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Spain Key country dynamics
  • Fig. 51 Italy cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Key country dynamics
  • Fig. 53 Denmark cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Key country dynamics
  • Fig. 55 Sweden cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Key country dynamics
  • Fig. 57 Norway cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway Key country dynamics
  • Fig. 59 Asia Pacific cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan Key country dynamics
  • Fig. 62 China cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China Key country dynamics
  • Fig. 64 India cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India Key country dynamics
  • Fig. 66 Australia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia Key country dynamics
  • Fig. 68 South Korea cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea Key country dynamics
  • Fig. 70 Thailand cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand Key country dynamics
  • Fig. 72 Latin America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil Key country dynamics
  • Fig. 75 Argentina cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina Key country dynamics
  • Fig. 77 MEA cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa Key country dynamics
  • Fig. 80 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia Key country dynamics
  • Fig. 82 UAE cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Key country dynamics
  • Fig. 84 Kuwait cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait Key country dynamics
  • Fig. 86 Market participant categorization
  • Fig. 87 Strategic framework